Johns Hopkins Ciccarone Center (@ciccaronecenter) 's Twitter Profile
Johns Hopkins Ciccarone Center

@ciccaronecenter

Official Twitter account of the #Ciccarone Center for the #Prevention of Cardiovascular Disease at @HopkinsMedicine and @JohnsHopkins #FacingOffAgainstCVD

ID: 1216953666311245824

linkhttps://www.hopkinsmedicine.org/heart_vascular_institute/cardiology/ciccarone/ calendar_today14-01-2020 05:22:34

1,1K Tweet

1,1K Followers

1,1K Following

Roger Blumenthal (@rblument1) 's Twitter Profile Photo

This review provides important information on the major domains of social determinants of health (SDOH) in context of ASCVD… ⁦Wendy Post⁩ ⁦Johns Hopkins Ciccarone CenterJohns Hopkins CardiologyDr. Laxmi Mehta⁩ #BIG10 ⁦Kim Eagle⁩ Source: SpringerLink search.app/oemkbCJ3Pd7AJt…

Johns Hopkins Ciccarone Center (@ciccaronecenter) 's Twitter Profile Photo

What are some of the perceived barriers to routinely measuring lipoprotein (a) for adults >18 years old at your institution #CVDPrevention #CardioTwitter Johns Hopkins Cardiology

Johns Hopkins Ciccarone Center (@ciccaronecenter) 's Twitter Profile Photo

What is the recommended duration of treatment for - patients who have been prescribed weight (wt) loss medications like semaglutide (Wigovey or Ozempic) and Tirzepatide (Mounjaro or Zepbound). #CVDPrevention Johns Hopkins Cardiology

Cian McCarthy (@cianpmccarthy) 's Twitter Profile Photo

Out today in European Society of Cardiology Journals the new ESC 2024 GL for elevated BP and hypertension led by co-chairs John William McEvoy and Prof Rhian Touyz. Honored to serve as a task-force co-ordinator and writing comittee member alongside Rosa Maria Bruno. #ESCCongress Thread/

Out today in <a href="/ESC_Journals/">European Society of Cardiology Journals</a> the new ESC 2024 GL for elevated BP and hypertension led by co-chairs <a href="/johnwmcevoy/">John William McEvoy</a> and Prof Rhian Touyz. Honored to serve as a task-force co-ordinator and writing comittee member alongside <a href="/rosam_bruno/">Rosa Maria Bruno</a>. #ESCCongress

Thread/
Johns Hopkins Ciccarone Center (@ciccaronecenter) 's Twitter Profile Photo

Which trial being presented this weekend at ESC are you most excited about? 1. STEEER-AF: Stroke prevention and rhythm control therapy in Afib. 2. FINEARTS-HF: use of finerenone in patients with HFmrEF and HFpEF. 3. 30-year CVOs Based on CRP, LDL-C, and LP(a) #ESCCongress

Allison G. Hays, MD (@allisonghaysmd) 's Twitter Profile Photo

Prevention of Cardiovascular Disease — Don’t Stop Thinking about Tomorrow | NEJM nejm.org/doi/full/10.10… Outstanding editorial by friends and colleagues on long term risk of CVD Johns Hopkins Cardiology Johns Hopkins Ciccarone Center Roger Blumenthal @sethshaymart Johns Hopkins Department of Medicine NEJM

Roger Blumenthal (@rblument1) 's Twitter Profile Photo

The ⁦Johns Hopkins Ciccarone Center⁩ is proud to announce the promotion of Dr. Elizabeth Ratchford, Director of Vascular Medicine ⁦Johns Hopkins Cardiology⁩, to Clinical Professor of Medicine at Johns Hopkins! #🥍🏃‍♀️🏏⚽️🏈🎾

The ⁦<a href="/CiccaroneCenter/">Johns Hopkins Ciccarone Center</a>⁩ is proud to announce the promotion of Dr. Elizabeth Ratchford, Director of Vascular Medicine ⁦<a href="/hopkinsheart/">Johns Hopkins Cardiology</a>⁩, to Clinical Professor of Medicine at Johns Hopkins! #🥍🏃‍♀️🏏⚽️🏈🎾